Hitoshi Goi

Title: Hitoshi Goi: Innovator in Pharmaceutical Processes

Introduction

Hitoshi Goi is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of various chemical compounds. With a total of 3 patents to his name, Goi's work has implications for both bactericides and herbicides.

Latest Patents

One of Goi's latest patents involves a process for the optical resolution of L-2-Amino-4-methylphosphinobutyric acid (L-MPGA). This compound is useful as a bactericide and herbicide and can be prepared by optically resolving its racemic mixture, D,L-MPGA, using a microbial acylase. The process entails providing D,L-MPGA in the form of its N-acyl derivative and reacting it in an aqueous medium with a microbial acylase that has an optically specific hydrolytic activity. This selective reaction eliminates the acyl group of N-acyl-L-MPGA, resulting in a mixture of L-MPGA and N-acyl-D-MPGA, from which L-MPGA can be isolated. The acylase is produced by cultivating specific microbial strains, including Pseudomonas maltophilia BN-233 and Aspergillus sp. KS-102.

Another significant patent by Goi focuses on the preparation of 7-amino-cephem compounds using mold fungi. These compounds are characterized by a general formula that includes various functional groups. The preparation involves the action of a cephalosporin C acylase-producing strain of a microorganism on specific compounds in an aqueous medium.

Career Highlights

Hitoshi Goi is associated with Meiji Seika Kaisha, Ltd., a company known for its advancements in the pharmaceutical industry. His work has contributed to the development of innovative processes that enhance the efficacy of pharmaceutical compounds.

Collaborations

Goi has collaborated with notable coworkers, including Tomizo Niwa and Shinji Miyado. Their combined expertise has likely fostered advancements in their respective fields.

Conclusion

Hitoshi Goi's contributions to pharmaceutical processes demonstrate his innovative spirit and commitment to advancing chemical sciences. His patents reflect a deep understanding of microbial applications in drug development, paving the way for future advancements in the industry.